脑梗死二级预防患者阿托伐他汀依从性降低的危险因素分析

doi:10.3969/j.issn.10073205.2019.02.007

河北医科大学学报

脑梗死二级预防患者阿托伐他汀依从性降低的危险因素分析

1.冀中能源峰峰集团有限公司九龙服务分公司医院内科，河北邯郸 056500；2.冀中能源峰峰集团有限公司总医院神经内科，
河北邯郸 056200；3.冀中能源峰峰集团有限公司总医院药学部，河北邯郸 056200；
4.冀中能源峰峰集团有限公司总医院CT/MR室，河北邯郸 056200

出版日期:2019-02-25 发布日期:2019-01-16
作者简介:陈梅（1972-），女，四川荣县人，冀中能源峰峰集团有限公司九龙服务分公司医院副主任护师，从事临床护理学研究。
基金资助:
河北省医学科学研究重点课题（20181744）

Analysis of risk factors about reduced atorvastatin compliance in patients with cerebral infarction secondary prevention#br#

1.Department of Internal Medicine， Jiulong Service Branch Hospital of Jizhong Energy Fengfeng Group
Co., LTD., Hebei Province, Handan 056500, China; 2.Department of Neurology,General Hospital of
Jizhong Energy Fengfeng Group Co., LTD., Hebei Province, Handan 056200, China; 3.Department of
Pharmacy,General Hospital of Jizhong Energy Fengfeng Group Co., LTD., Hebei Province, Handan
056200, China; 4.CT/MR Room, General Hospital of Jizhong Energy Fengfeng
Group Co., LTD., Hebei Province, Handan 056200, China

Online:2019-02-25 Published:2019-01-16

摘要/Abstract

摘要： ［摘要］〓
〖HTH〗目的〖HTSS〗〖KG*2〗探讨脑梗死二级预防患者阿托伐他汀依从性降低的危险因素。
〖HTH〗方法〖HTSS〗〖KG*2〗选择急性脑梗死患者546例随访3个月。依据阿托伐他汀依从性分为依从性降低组和依从性未降低组，比较2组性别，年龄，神经功能评分，药物不同日用量例数，经济问题、中药替代、指导异常、遗忘误解、不良反应、缺乏信心发生率。分析脑梗死二级预防患者阿托伐他汀依从性降低的危险因素。
〖HTH〗结果〖HTSS〗〖KG*2〗调查结束时，21例患者失访，实际完成研究525例，其中患者阿托伐他汀依从性降低281例（53.5%）。依从性降低组与依从性未降低组性别、年龄、NIHSS评分、mRs评分和阿托伐他汀日用量差异无统计学意义（P＞005）；依从性降低组经济问题、中药替代、指导异常、遗忘误解、不良反应、缺乏信心发生率明显高于依从性未降低组，差异有统计学意义（P＜005）。多元Logistic回归分析结果显示，经济问题、中药替代、指导异常、遗忘误解、不良反应、缺乏信心是阿托伐他汀依从性降低的危险因素。
〖HTH〗结论〖HTSS〗〖KG*2〗针对上述主观原因采取行之有效的措施，可减少甚至消除脑梗死二级预防期间阿托伐他汀依从性降低。

关键词: 脑梗死, 阿托伐他汀, 服药依从性

Abstract: ［Abstract］〓Objective〖HTSS〗〓To investigate the risk factors about reduced atorvastatin compliance in patients with cerebral infarction secondary prevention.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓The 546 patients with acute cerebral infarction were followed up for 3 months. All patients were divided into two groups according to the decrease of atorvastatin compliance or not. The following factors were compared between the two groups, including sex, age, neurological function, the number of patients with different daily doses of atorvastatin and incidence of following subjective causes, included economic problems, substitution of traditional Chinese medicine, abnormal guidance, forgetting and misunderstandings, adverse reactions and lack of confidence. Risk factors of reduced compliance of atorvastatin in patients with secondary prevention of cerebral infarction were analyzed.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓At the end of the investigation, 21 patients lost their visits and 525 patients completed the study, among which 281 patients (53.5%) had decrease of atorvastatin compliance. There was no significant difference on sex, age, neurological function and the number of patients with different daily doses of atorvastatin between two groups(P＞005). The incidence of economic problems, substitution of traditional Chinese medicine, abnormal guidance, forgetting and misunderstandings, adverse reactions and lack of confidence in the decrease of atorvastatin compliance group were significantly higher than those in the not decrease of atorvastatin compliance group(P＜005). Economic problems, substitution of traditional Chinese medicine, abnormal guidance, forgetting and misunderstandings, adverse reactions and lack of confidence were the risk factors about reduced atorvastatin compliance by multivariate Logistic regression analysis.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Taking effective measures against the above subjective causes may reduce or even eliminate the decrease of atorvastatin compliance during the secondary prevention of cerebral infarction.

Key words: brain infarction； atorvastatin, medication adherence

陈〓梅1，郭明升2*，刘〓娟2，武〓华3，马普红4. 脑梗死二级预防患者阿托伐他汀依从性降低的危险因素分析[J]. 河北医科大学学报, doi: 10.3969/j.issn.10073205.2019.02.007.

CHEN Mei1, GUO Mingsheng2*, LIU Juan2, WU Hua3, MA Puhong4. Analysis of risk factors about reduced atorvastatin compliance in patients with cerebral infarction secondary prevention#br#[J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.10073205.2019.02.007.

[1]	康丽娟, 李盼, 耿丽颖, 孟琦. 补体激活3a受体检测评估大剂量阿托伐他汀联合双联抗血小板治疗急性脑梗死的效果研究 [J]. 河北医科大学学报, 2023, 44(9): 1011-1016.
[2]	王琳, 徐正虎, 李可静, 范鸣玥, 王恒. DEVT与BT方案治疗急性大血管闭塞性脑梗死患者的效果及对预后的影响 [J]. 河北医科大学学报, 2023, 44(7): 786-791.
[3]	王荣辉, 王小卫, 张博刚. 替罗非班联合Solumbra取栓对急性颅内外大动脉闭塞脑梗死血管再通率及预后的影响 [J]. 河北医科大学学报, 2023, 44(7): 792-797.
[4]	何琴, 杨小芳, 康瑜, 殷成坤. 脑梗死继发癫痫患者脑干听觉诱发电位与脑血流量相关性及意义 [J]. 河北医科大学学报, 2023, 44(7): 798-802,823.
[5]	张颖, 王佳荣, 张二娜, 赵智江, 陈晓艳, 刘芳芳. AIM2、Lp-PLA2、UCH-L1在急性脑梗死中的表达及预测价值研究 [J]. 河北医科大学学报, 2023, 44(4): 386-391.
[6]	刘梓宸 , 李克娇, 畅莎, 宋雪, 李芳. RBP、miR-126、Sirt1在急性脑梗死中的表达及与颈动脉粥样硬化斑块稳定性的相关性 [J]. 河北医科大学学报, 2023, 44(2): 142-147.
[7]	焦俊萍, 鲍军强, 王志伟, 田书娟. 依达拉奉右莰醇对急性脑梗死静脉溶栓后的疗效观察[J]. 河北医科大学学报, 2022, 43(8): 884-889.
[8]	逯青丽, 刘仲仲, 刘佩, 王静, 蔺雪梅, 吴松笛. 老年首发脑梗死患者卒中相关性肺炎发生的危险因素及对早期结局的影响 [J]. 河北医科大学学报, 2022, 43(8): 890-894，914.
[9]	闫菁. 老年脑梗死后肩手综合征患者康复治疗效果相关影响因素的调查分析 [J]. 河北医科大学学报, 2022, 43(7): 839-843.
[10]	张红金, 顾金涛, 徐红梅. 老年H型高血压伴急性脑梗死患者外周血LP-PLA2、S100-β与病情严重程度及预后的关系分析 [J]. 河北医科大学学报, 2022, 43(12): 1378-1383.
[11]	马悦霞, 冯俊艳, 孙淑华, 王倩茹, 张笑, 祝春华. 缺血性脑血管病出院患者用药依从性现状及影响因素研究[J]. 河北医科大学学报, 2022, 43(1): 16-21.
[12]	陈灏, 胡菁菁. 联合检测hs-CRP、Hcy和凝血功能对急性脑梗死病情严重程度的评估价值分析 [J]. 河北医科大学学报, 2021, 42(6): 641-645.
[13]	逯青丽, 王静, 刘仲仲, 蔺雪梅, 王芳, 吴松笛. 西安地区伴吞咽障碍老年急性脑梗死患者的临床特征及对住院结局的影响 [J]. 河北医科大学学报, 2021, 42(6): 646-650.
[14]	唐甲凡, 翟万庆, 宋丽艳, 何晓燕, 周亦. 多种血清指标预测老年脑卒中后抑郁的临床价值[J]. 河北医科大学学报, 2021, 42(6): 651-655,660.
[15]	张鑫宇, 赵鑫, 张重阳, 王耀辉, 刘宇鹏. 局部亚低温联合rt-PA静脉溶栓治疗对急性大面积脑梗死患者氧化应激、神经功能损伤及预后的影响[J]. 河北医科大学学报, 2021, 42(2): 158-162.

脑梗死二级预防患者阿托伐他汀依从性降低的危险因素分析

Analysis of risk factors about reduced atorvastatin compliance in patients with cerebral infarction secondary prevention#br#

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价